{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T23:50:34Z","timestamp":1775605834493,"version":"3.50.1"},"reference-count":27,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T00:00:00Z","timestamp":1758844800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Revue Neurologique"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.neurol.2025.08.005","type":"journal-article","created":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T15:43:21Z","timestamp":1762962201000},"page":"909-914","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Presymptomatic detection of spinal muscular atrophy: Ongoing revolution for a devastating disorder"],"prefix":"10.1016","volume":"181","author":[{"given":"V.","family":"Laugel","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.neurol.2025.08.005_bib0140","doi-asserted-by":"crossref","first-page":"49","DOI":"10.3390\/ijns10030049","article-title":"Systematic review of newborn screening programmes for spinal muscular atrophy","volume":"10","author":"Cooper","year":"2024","journal-title":"Int J Neonatal Screen"},{"issue":"9","key":"10.1016\/j.neurol.2025.08.005_bib0145","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1001\/jamapediatrics.2024.1911","article-title":"Newborn screening and birth prevalence for spinal muscular atrophy in the US","volume":"178","author":"Belter","year":"2024","journal-title":"JAMA Pediatr"},{"issue":"6","key":"10.1016\/j.neurol.2025.08.005_bib0150","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1001\/jamapediatrics.2024.0492","article-title":"Clinical Effectiveness of newborn screening for spinal muscular atrophy: a nonrandomized controlled trial","volume":"178","author":"Schwartz","year":"2024","journal-title":"JAMA Pediatr"},{"issue":"1","key":"10.1016\/j.neurol.2025.08.005_bib0155","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1038\/s41572-022-00380-8","article-title":"Spinal muscular atrophy","volume":"8","author":"Mercuri","year":"2022","journal-title":"Nat Rev Dis Primers"},{"issue":"1","key":"10.1016\/j.neurol.2025.08.005_bib0160","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1111\/cge.14714","article-title":"Rare cause 5q SMA: molecular genetic and clinical analyses of intragenic subtle variants in the SMN locus","volume":"108","author":"Mikhalchuk","year":"2025","journal-title":"Clin Genet"},{"issue":"3","key":"10.1016\/j.neurol.2025.08.005_bib0165","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.nmd.2014.11.012","article-title":"Motor unit loss estimation by the multipoint incremental MUNE method in children with spinal muscular atrophy\u00a0\u2013\u00a0a preliminary study","volume":"25","author":"Gawel","year":"2015","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.neurol.2025.08.005_bib0170","doi-asserted-by":"crossref","first-page":"115230","DOI":"10.1016\/j.expneurol.2025.115230","article-title":"Mechanisms of functional improvement behind nusinersen treatment in adult spinal muscular atrophy","volume":"389","author":"Hsieh","year":"2025","journal-title":"Exp Neurol"},{"issue":"8","key":"10.1016\/j.neurol.2025.08.005_bib0175","doi-asserted-by":"crossref","first-page":"6307","DOI":"10.1007\/s12035-017-0831-9","article-title":"Time is motor neuron: therapeutic window and its correlation with pathogenetic mechanisms in spinal muscular atrophy","volume":"55","author":"Govoni","year":"2018","journal-title":"Mol Neurobiol"},{"issue":"2","key":"10.1016\/j.neurol.2025.08.005_bib0180","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1002\/mus.27853","article-title":"Continued benefit of nusinersen initiated in the presymptomatic stage of spinal muscular atrophy: 5-year update of the NURTURE study","volume":"68","author":"Crawford","year":"2023","journal-title":"Muscle Nerve"},{"issue":"7","key":"10.1016\/j.neurol.2025.08.005_bib0185","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1038\/s41591-022-01867-3","article-title":"Onasemnogene abeparvovec for presymptomatic infants with three copies of SMN2 at risk for spinal muscular atrophy: the phase III SPR1NT trial","volume":"28","author":"Strauss","year":"2022","journal-title":"Nat Med"},{"issue":"7","key":"10.1016\/j.neurol.2025.08.005_bib0190","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1038\/s41591-022-01866-4","article-title":"Onasemnogene abeparvovec for presymptomatic infants with two copies of SMN2 at risk for spinal muscular atrophy type 1: the Phase III SPR1NT trial","volume":"28","author":"Strauss","year":"2022","journal-title":"Nat Med"},{"issue":"Suppl. 1","key":"10.1016\/j.neurol.2025.08.005_bib0195","article-title":"RAINBOWFISH: 2-year efficacy and safety data of risdiplam in infants with presymptomatic SMA","volume":"43","author":"Servais","year":"2024","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.neurol.2025.08.005_bib0200","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.jpeds.2017.06.042","article-title":"Presymptomatic diagnosis of spinal muscular atrophy through newborn screening","volume":"190","author":"Chien","year":"2017","journal-title":"J Pediatr"},{"issue":"1","key":"10.1016\/j.neurol.2025.08.005_bib0205","doi-asserted-by":"crossref","first-page":"19922","DOI":"10.1038\/s41598-021-99496-2","article-title":"Three years pilot of spinal muscular atrophy newborn screening turned into official program in Southern Belgium","volume":"11","author":"Boemer","year":"2021","journal-title":"Sci Rep"},{"issue":"2","key":"10.1016\/j.neurol.2025.08.005_bib0210","doi-asserted-by":"crossref","first-page":"26","DOI":"10.3390\/ijns7020026","article-title":"Massachusetts\u2019 findings from statewide newborn screening for spinal muscular atrophy","volume":"7","author":"Hale","year":"2021","journal-title":"Int J Neonatal Screen"},{"issue":"6","key":"10.1016\/j.neurol.2025.08.005_bib0215","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1002\/mus.28267","article-title":"Outcomes of early-treated infants with spinal muscular atrophy: a multicenter, retrospective cohort study","volume":"70","author":"Goedeker","year":"2024","journal-title":"Muscle Nerve"},{"issue":"4","key":"10.1016\/j.neurol.2025.08.005_bib0220","doi-asserted-by":"crossref","first-page":"e200310","DOI":"10.1212\/CPJ.0000000000200310","article-title":"Spinal muscular atrophy update in best practices: recommendations for diagnosis considerations","volume":"14","author":"Schroth","year":"2024","journal-title":"Neurol Clin Pract"},{"key":"10.1016\/j.neurol.2025.08.005_bib0225","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.ejpn.2024.06.001","article-title":"2024 update: European consensus statement on gene therapy for spinal muscular atrophy","volume":"51","author":"Kirschner","year":"2024","journal-title":"Eur J Paediatr Neurol"},{"issue":"3","key":"10.1016\/j.neurol.2025.08.005_bib0230","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1002\/ana.26299","article-title":"Ethical perspectives on treatment options with spinal muscular atrophy patients","volume":"91","author":"Yeo","year":"2022","journal-title":"Ann Neurol"},{"issue":"5","key":"10.1016\/j.neurol.2025.08.005_bib0235","doi-asserted-by":"crossref","first-page":"2787","DOI":"10.1007\/s00415-024-12188-5","article-title":"5qSMA: standardised retrospective natural history assessment in 268 patients with four copies of SMN2","volume":"271","author":"Vill","year":"2024","journal-title":"J Neurol"},{"issue":"2","key":"10.1016\/j.neurol.2025.08.005_bib0240","doi-asserted-by":"crossref","first-page":"e200222","DOI":"10.1212\/NXG.0000000000200222","article-title":"Spectrum of phenotypes in SMA patients with 4 SMN2 copies in the French population: Registre SMA France","volume":"11","author":"Gerin","year":"2025","journal-title":"Neurol Genet"},{"issue":"5","key":"10.1016\/j.neurol.2025.08.005_bib0245","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1177\/22143602251336862","article-title":"Systematic review for economic evaluations on newborn screening for spinal muscular atrophy","volume":"12","author":"Pace","year":"2025","journal-title":"J Neuromuscul Dis"},{"issue":"10479","key":"10.1016\/j.neurol.2025.08.005_bib0250","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/S0140-6736(25)00048-0","article-title":"Spinal muscular atrophy in the UK: the human toll of slow decisions","volume":"405","author":"Servais","year":"2025","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.neurol.2025.08.005_bib0255","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.nmd.2023.02.004","article-title":"A new score combining compound muscle action potential (CMAP) amplitudes and motor score is predictive of motor outcome after AVXS-101 (Onasemnogene Abeparvovec) SMA therapy","volume":"33","author":"Barrois","year":"2023","journal-title":"Neuromuscul Disord"},{"issue":"5","key":"10.1016\/j.neurol.2025.08.005_bib0260","doi-asserted-by":"crossref","first-page":"e213371","DOI":"10.1212\/WNL.0000000000213371","article-title":"Long-term dynamics of CSF and serum neurofilament light chain in adult patients with 5q spinal muscular atrophy treated with nusinersen","volume":"104","author":"Cordts","year":"2025","journal-title":"Neurology"},{"issue":"11","key":"10.1016\/j.neurol.2025.08.005_bib0265","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1056\/NEJMc2300802","article-title":"Risdiplam for prenatal therapy of spinal muscular atrophy","volume":"392","author":"Finkel","year":"2025","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.neurol.2025.08.005_bib0270","doi-asserted-by":"crossref","first-page":"143","DOI":"10.3233\/JND-230136","article-title":"Impaired neurodevelopment in children with 5q-SMA\u00a0\u2013\u00a02 years after newborn screening","volume":"11","author":"K\u00f6lbel","year":"2024","journal-title":"J Neuromuscul Dis"}],"container-title":["Revue Neurologique"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0035378725006071?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0035378725006071?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,15]],"date-time":"2025-11-15T03:35:57Z","timestamp":1763177757000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0035378725006071"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":27,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["S0035378725006071"],"URL":"https:\/\/doi.org\/10.1016\/j.neurol.2025.08.005","relation":{},"ISSN":["0035-3787"],"issn-type":[{"value":"0035-3787","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Presymptomatic detection of spinal muscular atrophy: Ongoing revolution for a devastating disorder","name":"articletitle","label":"Article Title"},{"value":"Revue Neurologique","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neurol.2025.08.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}]}}